Multifaceted evaluation of central post–stroke pain

Nobuhiko Mori, Koichi Hosomi, Masahiko Shibata, Haruhiko Kishima, Youichi SaitohPAIN 2020 · DOI

Abstract

Objective: The goal of treating chronic pain is becoming more focused on improving Activities of Daily Living (ADL) and Quality of Life (QOL) than on pain itself. In this study, we evaluated patients with central post–stroke pain (CPSP) by a multifaceted evaluation and examined factors related to ADL and QOL.

Introduction

Central post-stroke pain (CPSP) is a debilitating neuropathic condition resulting from damage to the somatosensory system following a stroke. Traditionally, clinical success in treating CPSP has been measured primarily through pain intensity scales, such as the Visual Analogue Scale (VAS). However, a reduction in pain intensity does not always translate to improved functional outcomes for the patient.

Recent clinical shifts emphasize the importance of Activities of Daily Living (ADL) and overall Quality of Life (QOL) as primary treatment goals. This study aims to identify the multifaceted factors—including motor function, sensory disturbance, and psychological state—that independently predict functional recovery and life quality in CPSP patients.

Methods and Patient Cohort

This prospective study involved 41 patients diagnosed with either "definite" or "probable" CPSP. The researchers utilized a comprehensive battery of validated clinical scales to capture the complex nature of the condition:

  • Neurological Function: Stroke Impairment Assessment Set (SIAS-motor) for motor function and specific sensory disturbance assessments.
  • Pain Characterization: VAS for intensity and the Short-form McGill Pain Questionnaire 2 (SF-MPQ2) to differentiate between continuous, intermittent, neuropathic, and affective pain components.
  • Psychological Assessment: Hospital Anxiety and Depression Scale (HADS), Pain Catastrophizing Scale (PCS), and Beck Depression Inventory (BDI-II).
  • Outcome Metrics: Pain Disability Assessment Scale (PDAS) for ADL and the EQ-5D-5L for QOL.
Table 1: Patient demographics and clinical characteristics, detailing the cohort of 41 patients.

Statistical analysis included univariate Pearson correlations followed by stepwise multivariate regression using the Bayesian Information Criterion (BIC) to determine independent predictors of disability and QOL.

Results

Predictors of Disability (ADL)

Univariate analysis revealed that disability (PDAS) was strongly correlated with motor disturbance ($r = -0.67, p < 0.01$) and various pain scales ($r \approx 0.31, p = 0.04$). Crucially, the multivariate regression model identified motor impairment (SIAS-motor) as the most significant independent predictor of ADL disability, followed by the qualitative nature of the pain (SF-MPQ2).

Predictors of Quality of Life (QOL)

Quality of Life (EQ-5D-5L) showed significant correlations across nearly all measured domains, including motor function ($r = 0.55$), pain intensity ($r = -0.48$), and depression ($r = -0.56$). The multivariate model for QOL was more complex, incorporating motor function, pain quality, sensory disturbance, and depressive symptoms as significant factors.

Table 2: Stepwise multivariate regression analysis identifying independent variables for PDAS and EQ-5D-5L.

Discussion and Limitations

The findings suggest that motor function is a more critical driver of daily disability than pain intensity alone in CPSP patients. Furthermore, QOL is a holistic metric influenced by a combination of physical, sensory, and psychological factors. This underscores the need for a multidisciplinary approach to treatment that integrates intensive physical therapy and psychological support alongside traditional pain management.

Limitations: 1. Sample Size: The study's cohort of 41 patients may limit the ability to detect subtle interactions. 2. Study Design: As a cross-sectional study, it identifies correlations rather than definitive causal relationships. 3. Pain Heterogeneity: Distinguishing between central neuropathic pain and secondary musculoskeletal pain in stroke survivors remains a clinical challenge.

Future research should prioritize ADL and QOL as primary endpoints in clinical trials for CPSP treatments.

Summary updated

Abstract

Objective: The goal of treating chronic pain is becoming more focused on improving ADL and QOL than on pain itself. In this study, we evaluated patients with central post–stroke pain (CPSP) by a multifaceted evaluation and examined factors related to ADL and QOL.
BibTeX
@inproceedings{mori2020multifaceted,
  author = {Nobuhiko Mori and Koichi Hosomi and Masahiko Shibata and Haruhiko Kishima and Youichi Saitoh},
  title = {{Multifaceted evaluation of central post–stroke pain}},
  booktitle = {PAIN},
  year = {2020},
  doi = {10.11154/pain.35.99},
}
Figure